Lisdexamfetamine Dimesylate Capsule
Hikma Pharmaceuticals USA, Inc. · Limited Availability · Reason: Shortage of an active ingredient
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 07/14/2023
- Package NDC
- 0054-0373-25
- Generic name
- Lisdexamfetamine Dimesylate Capsule
- Contact info
- 800-631-2174
- Availability
- Limited Availability
- Related info
- Available on allocation
- Update date
- 09/18/2026
- Dosage form
- Capsule
- Presentation
- Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0054-0373-25)
- Company name
- Hikma Pharmaceuticals USA, Inc.
- Shortage reason
- Shortage of an active ingredient
- Status
- Current
- Therapeutic category
- Psychiatry
- Harmonized identifiers (openFDA)
- Application number
- ANDA202827
- Brand name
- LISDEXAMFETAMINE DIMESYLATE
- Generic name
- LISDEXAMFETAMINE DIMESYLATE
- Manufacturer name
- Hikma Pharmaceuticals USA Inc.
- Product NDC
- 0054-0373, 0054-0660, 0054-0370, 0054-0371, 0054-0372, 0054-0374, 0054-0375
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- LISDEXAMFETAMINE DIMESYLATE
- RxCUI
- 854830, 854834, 854838, 854842, 854846, 854850, 1593856
- SPL ID
- ccd9e87c-bd03-4fe0-8129-41c1ced49c8d
- SPL set ID
- 6740a621-9bec-4178-a4fc-a3fc89f34e0a
- Package NDC
- 0054-0660-25, 0054-0370-25, 0054-0371-25, 0054-0372-25, 0054-0373-25, 0054-0374-25, 0054-0375-25
- UNII
- SJT761GEGS